Beijing Tong Ren Tang Co.,Ltd. (600085.SH) announced that its subsidiary, Beijing Tong Ren Tang Pharmaceutical Factory, has received a "Product License (Category III)" issued by Health Canada. The subsidiary's product, Hemp Seed Pills (Ma Ren Run Chang Wan), has been officially registered in Canada.
The approved indication is: A traditional Chinese medicine formulation used to relieve chest and abdominal distension and constipation caused by gastrointestinal heat accumulation. The product is traditionally used to lubricate the intestines and promote bowel movements.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments